Wayne Shiong
Investor @ Singleron Biotechnologies
Beijing, China
Wayne Shiong is a Series A investor at Singleron Biotechnologies in Beijing focused on Software and Life Science. Wayne Shiong is the Partner of China Growth Capital. Wayne attended Peking University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Wayne Shiong invests in
Stages Wayne Shiong invests in
Countries Wayne Shiong invests in
Investment Focus
Industry
- Software 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
- Information Services 1 (50%)
- Information Technology 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
InxMed
|
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M / Series A / Sep 04, 2020 | |
DeePhi Tech
|
Founded in 2016, DeePhi Tech aims to be a recognized leader in deep learning acceleration. They provide end-to-end solutions utilizing deep compression and a DPU platform. Through synergistic optimization of neural networks and FPGAs, DeePhi provides more efficient, convenient and economical inference platforms for both embedded end and sever-side,including but not limited to data centers and surveillance. | $40M / Series A / Oct 24, 2017 |
Co-Investors
About Singleron Biotechnologies
Singleron Biotechnologies is a developer and provider of clinical diagnosis, health management and drug development products and services. The company is dedicated to applying single cell analysis techniques and has obtained a world wide exclusive IP license from Yale University for its uniquely designed microfluidic single cell processing device,and has developed the innovative SCOPE single-cell pre-sequencing preparation system based on this microfluidic device.
Singleron Biotechnologies Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andreas Schmidt
Senior Vice President, Global Business Development
|
|||
Jing Zhou
Founder &Vice President Of Engineering
|
|||
Nan Fang
Founder and Chief Executive Officer
|
|||
|
Wayne Shiong
Investor
|
|||
Yifeng Gao
Chief Financial Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wayne Shiong invest in?
Wayne Shiong invests primarily in Software, Life Science and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Wayne Shiong last invest?
The most recent investment recorded for Wayne Shiong closed in Sep 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
